FDA Launches New Program to Advance Neuroscience Medical Product Development
FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


